Crohn's Disease and Colitis Trial, Recruiting (NCT06516341)

Crohn's Disease and Colitis Trial, Recruiting NCT06516341 Sponsor: IRCCS Ospedale San Raffaele Condition: Crohn's Disease and Colitis

Printed from Voxsanity (voxsanity.com.au) — NCT06516341 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Crohns Disease And Colitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are an adult aged 18 or older who has been diagnosed with Crohn's disease or ulcerative colitis (confirmed by a tissue/biopsy test) and are having part of your bowel surgically removed because of narrowing or blockages in your intestine
You may be able to join regardless of what medications you are currently taking or have taken in the past
Pregnant or breastfeeding patients may also be included, as this is an observational study (one that watches and records rather than giving any new treatment)
You are willing and able to read and sign a consent form agreeing to take part

Who may not be able to join:

You are under 18 years old or over 70 years old
Your diagnosis of Crohn's disease or ulcerative colitis has not been officially confirmed
You have been found to have abnormal cell changes (dysplasia) or cancer alongside your bowel condition, or your surgery would make it impossible to carry out a follow-up camera examination (endoscopy) of the bowel afterwards
You are unwilling or unable to sign the consent form

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +39 0226436275

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06516341

Sponsor: IRCCS Ospedale San Raffaele

Phase: Not Applicable

Status: Recruiting

Condition: Crohn's Disease and Colitis

Trial contact: +39 0226436275

More information: https://clinicaltrials.gov/study/NCT06516341

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are an adult aged 18 or older who has been diagnosed with Crohn's disease or ulcerative colitis (confirmed by a tissue/biopsy test) and are having part of your bowel surgically removed because of narrowing or blockages in your intestine
You may be able to join regardless of what medications you are currently taking or have taken in the past
Pregnant or breastfeeding patients may also be included, as this is an observational study (one that watches and records rather than giving any new treatment)
You are willing and able to read and sign a consent form agreeing to take part

Who may not be able to join:

You are under 18 years old or over 70 years old
Your diagnosis of Crohn's disease or ulcerative colitis has not been officially confirmed
You have been found to have abnormal cell changes (dysplasia) or cancer alongside your bowel condition, or your surgery would make it impossible to carry out a follow-up camera examination (endoscopy) of the bowel afterwards
You are unwilling or unable to sign the consent form

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

IRCCS Ospedale San Raffaele

Registry

ClinicalTrials.gov

Start date

27 February 2025

Est. completion

1 September 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

To define spatial, cellular, and molecular characteristics of IBD-derived intestinal samples

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov